*Check back as more dates and locations will be announced soon!
|Asim Amin, MD, PhD – Levine Cancer Institute Carolinas Medical Center
Joseph W. Fay, MD – Baylor University Medical Center
Keith L. Knutson, PhD – Vaccine & Gene Therapy Institute of Florida
John D. Powderly II, MD, CPI – Carolina BioOncology Institute, PLLC
Brian I. Rini, MD – Cleveland Clinic Taussig Cancer Center
Alexander Spira, MD, PhD – Virginia Cancer Specialists
Specifically designed for clinical oncologists and the entire medical team involved in treating cancer patients with immunotherapy, these introductory, CME-certified programs will provide an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field.
Presented by leading authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of 1) the underlying principles of tumor immunology and immunotherapy, 2) the clinical indications for cancer immunotherapy and appropriate selection of patients, 3) patient management, and 4) the therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes.
Attendees can also take advantage of the opportunity for professional networking that will promote collaboration and scientific exchange with experts, clinical oncologists and other health care providers from the surrounding community.
The target audience for these programs includes clinical oncologists, those involved in patient care, early career individuals, allied health professionals, and patient advocates who wish to learn principles of tumor immunology and immunotherapy, as well as improve their ability to select patients for immunotherapy and provide state-of-the-art clinical management for their patients.
Upon completion of this program, the participants will be able to:
The Advances in Cancer Immunotherapy™ programs have been approved for continuing medical education credits by Clinical Immunology Society (CIS) and Society for Immunotherapy of Cancer (SITC)
For full accreditation information, please click on the regional ACI™ program links above.
This series of programs have been made possible in part by educational grants from:
To view all of SITC’s supporters, please, click here.